{
    "2019-02-19": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Roche's (RHHBY) BLA for Lymphoma Drug Gets Priority Review",
                "features": {
                    "keywords": [
                        "Roche",
                        "BLA",
                        "Lymphoma Drug",
                        "Priority Review"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-01-10",
                "original_text": "What Are Teva Pharmaceuticalâ€™s Key Growth Drivers in 2019?",
                "features": {
                    "keywords": [
                        "Teva",
                        "Pharmaceutical",
                        "Growth Drivers",
                        "2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}